The competition is far behind.

Eli Lilly is just wrapping up trials of its retatrutide, but consumers already are flocking to black-market versions. Can ...

IPO stock Omada Health easily beat first-quarter sales views Thursday, and announced a deal with drug titan Eli Lilly. But ...

There's a reason the world's most patient investors love dividend stocks. Market movements heavily influence a stock's ...

Mounjaro generated $8.66 billion in sales in the first quarter.

Deal volume in 2026 is substantially outpacing last year, and activity is being driven by interest in cancer and autoimmune ...

In France, Wegovy is prescribed as a second-line treatment for obesity, not for people with a lower body mass index (BMI) or ...

Eli Lilly and Company (NYSE: LLY) is one of the best stocks to buy for the next 15 years. On May 7, Eli Lilly executed its ...

Eli Lilly & Co has kicked off the sale of investment-grade debt as part of an effort to fund its acquisition spree.

For years, industry executives and investors have wondered when increasing institutional investment and rising research funds ...

Eli Lilly (NYSE:LLY) received another bullish call from Wall Street. Barclays analyst Emily Field raised her price target on ...

By Stine Jacobsen and Maggie Fick COPENHAGEN/LONDON, May 6 (Reuters) - Novo Nordisk beat first-quarter profit forecasts and ...